
Sano Genetics
Building the future of precision medicine with genomics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | - | |
Total Funding | 000k |
Related Content
Sano Genetics operates in the precision medicine research industry, providing a comprehensive platform that integrates genetic testing, participant recruitment, and long-term engagement to accelerate clinical trials. The company serves pharmaceutical companies, biotech firms, and academic researchers who are conducting personalized medicine studies. Sano's platform simplifies the complex process of DNA testing studies, making it more efficient and cost-effective. The business model is based on offering a tech-forward, user-friendly solution that de-risks trials, enabling clinical operations teams to move 10 times faster and reduce costs by 5 times. Revenue is generated through subscription fees and service charges for the use of their platform and additional support services. Sano's approach is human-centric, focusing on making research engaging, transparent, and meaningful for participants. The company also offers electronic medical record retrieval, providing up to seven years of curated medical history to support research efforts.
Keywords: precision medicine, genetic testing, clinical trials, participant recruitment, long-term engagement, DNA sequencing, biotech, pharmaceutical, personalized medicine, research platform.